AI assistant
Sending…
Anixa Biosciences Inc — Director's Dealing 2014
Jul 17, 2014
34117_dirs_2014-07-17_8acdf8a7-b510-4bc5-b6a7-ff0a95f9b907.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2014-07-08
Reporting Person: Stender Tisha (Chief Operating Officer)
More from Anixa Biosciences Inc
Regulatory Filings
2026
Mar 11
Interim / Quarterly Report
2026
Mar 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 29
Proxy Solicitation & Information Statement
2026
Jan 28
Regulatory Filings
2026
Jan 12
Annual Report
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6